Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis

Conclusion
Novel biomarkers, including IL-6, uNGAL and copeptin, can probably improve prognostication of patients with decompensated cirrhosis compared with MELD alone.

Source: Gut - December 7, 2023 Category: Gastroenterology Authors: Juanola, A., Ma, A. T., de Wit, K., Gananandan, K., Roux, O., Zaccherini, G., Jimenez, C., Tonon, M., Sole, C., Villaseca, C., Uschner, F. E., Graupera, I., Pose, E., Moreta, M. J., Campion, D., Beuers, U., Mookerjee, R. P., Francoz, C., Durand, F., Varga Tags: Gut Hepatology Source Type: research